Sneak Peak

Teresa Miceli |

The 62nd annual meeting of the American Society of Hematology (ASH) does not officially start until 12.4.2020. However, the multiple myeloma experts are always ahead of the curve, having the International Myeloma Working Group (IMWG) “breakfast” meeting 12.2.2020. This year, the meeting was again led by Dr. Brian Durie and Dr. Vincent Rajkumar. The International […]

Waist Deep in BiTES

Valarie Traynham |

At last year’s ASH meetings, I learned a tremendous amount about BiTES (bispecific T-cell engagers). I referenced it as getting my feet wet. This year I can say that I not only got my feet wet but was submerged waist deep in emerging Duo Body Bispecific antibodies (BsAbs). Bispecific antibodies, like CAR-T cell therapy are […]

The Prom Queen

John DeFlice |

“Bispecifics are the prom queens of ASH”—Tom Martin, M.D. Attending the virtual iteration of ASH has been a unique experience, in that I’ve had the opportunity to see many of the leading international myeloma experts all from the comfort of own home. One of the silver linings of a virtual symposium is that I have […]

Continuing to “Take A Bite” Out of Myeloma 2020  

Michael Tuohy |

Last year, in one of my ASH19 blogs, I wrote about  bi-specific T cell engager (BiTE) therapy. BiTEs excite me the most of the newer therapies in clinical trials. They harness the power of the immune system and are off-the-shelf, unlike CAR T where your T cells are harvested, then re-engineered, then given back to you […]